Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
BHVN
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
-1.32
vs -6.21
Q3.23
N/A
-1.50
vs -1.75
Q4.23
N/A
-1.81
vs -3.32
Q1.24
N/A
-2.20
vs -1.03
Q2.24
N/A
-3.64
vs -1.32
Q3.24
N/A
-1.70
vs -1.50
Q4.24
N/A
-1.85
vs -1.81
Q1.25
N/A
-2.17
vs -2.20
Q2.25
N/A
-1.90
vs -3.64
Q3.25
N/A
-1.90
vs -1.70
Sales Growth
YoY
Current
Estimates
Q2.23
-100%
NA vs 215.1M
Q3.23
NA
NA vs NA
Q4.23
+100%
NA vs -215079000
Q1.24
NA
NA vs NA
Q2.24
NA
NA vs NA
Q3.24
NA
NA vs NA
Q4.24
NA
NA vs NA
Q1.25
NA
NA vs NA
Q2.25
NA
1.6M vs NA
Q3.25
NA
643.7K vs NA
Return on Equity
QoQ
Q2.23
-23%
-0.23
vs -0.15
Q3.23
-35%
-0.35
vs -0.23
Q4.23
-34%
-0.34
vs -0.35
Q1.24
-60%
-0.60
vs -0.34
Q2.24
-83%
-0.83
vs -0.60
Q3.24
-51%
-0.51
vs -0.83
Q4.24
-44%
-0.44
vs -0.51
Q1.25
-85%
-0.85
vs -0.44
Institutionnal Ownership
QoQ
Q2.23
206
206
vs 192
7%
Q3.23
198
198
vs 206
-4%
Q4.23
232
232
vs 198
17%
Q1.24
266
266
vs 232
15%
Q2.24
236
236
vs 266
-11%
Q3.24
265
265
vs 236
12%
Q4.24
268
268
vs 265
1%
Q1.25
275
275
vs 268
3%
Forecast
NaN%2026-Revenue
-193%2026-EPS
137%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
0.00(-100.00%)
Number of analyst
0
Last analyst upgrade/downgrade
Jefferies
initialisePrevious: Not converted
2024-09-16
Now: Buy
Bernstein
initialisePrevious: Not converted
2024-09-04
Now: Outperform
Morgan Stanley
initialisePrevious: Not converted
2024-07-24
Now: Overweight
BTIG
initialisePrevious: Not converted
2022-12-02
Now: Buy
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
NYSE
Unprofitable
Unprofitable
0.02 ( 0.14%)
Pre-market 14.18$0.07 (0.50%)
Relative Strenght
0
Volume Buzz
-24%
Earning Acce
No
Dist 52w H.
75%
accessnewswire.com
9 hours ago
globenewswire.com
10 hours ago
prnewswire.com
10 hours ago
globenewswire.com
10 hours ago
globenewswire.com
12 hours ago
globenewswire.com
12 hours ago
Relative Strength
BHVN
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics